In 2022, Tran et al. reported a platform for modeling autosomal dominant polycystic kidney disease (ADPKD), where they induced genetic mutations in PKD1 and PKD2 in human pluripotent stem cells [139]. The gene discussed is PKD1; the disease is autosomal dominant polycystic kidney disease.